Replies to post #7549 on BioCorRx Inc. (BICX)

[Pip611]

On the road to FDA approval for an improved form of injectable naltrexone that last longer then the one Alkermes is selling now (VIVITROL). The improved formula TheraKine is developing sounds like it would last twice as long as VIVITROL.